EP2512545A2 - Patient fluid management system - Google Patents

Patient fluid management system

Info

Publication number
EP2512545A2
EP2512545A2 EP10838333A EP10838333A EP2512545A2 EP 2512545 A2 EP2512545 A2 EP 2512545A2 EP 10838333 A EP10838333 A EP 10838333A EP 10838333 A EP10838333 A EP 10838333A EP 2512545 A2 EP2512545 A2 EP 2512545A2
Authority
EP
European Patent Office
Prior art keywords
patient
infusion
fluid
data
providing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10838333A
Other languages
German (de)
English (en)
French (fr)
Inventor
Yasuhiro Kawamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
K&Y CORP
K and Y Corp
Original Assignee
K&Y CORP
K and Y Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by K&Y CORP, K and Y Corp filed Critical K&Y CORP
Priority claimed from PCT/US2010/061162 external-priority patent/WO2011075708A2/en
Publication of EP2512545A2 publication Critical patent/EP2512545A2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • A61B5/0215Measuring pressure in heart or blood vessels by means inserted into the body
    • A61B5/02152Measuring pressure in heart or blood vessels by means inserted into the body specially adapted for venous pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/02General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0244Micromachined materials, e.g. made from silicon wafers, microelectromechanical systems [MEMS] or comprising nanotechnology
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/02General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0272Electro-active or magneto-active materials
    • A61M2205/0294Piezoelectric materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • A61M2205/3334Measuring or controlling the flow rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • A61M2205/3341Pressure; Flow stabilising pressure or flow to avoid excessive variation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • A61M2205/3355Controlling downstream pump pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3546Range
    • A61M2205/3553Range remote, e.g. between patient's home and doctor's office
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/70General characteristics of the apparatus with testing or calibration facilities
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/30Blood pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14212Pumping with an aspiration and an expulsion action
    • A61M5/14228Pumping with an aspiration and an expulsion action with linear peristaltic action, i.e. comprising at least three pressurising members or a helical member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16831Monitoring, detecting, signalling or eliminating infusion flow anomalies
    • A61M5/16854Monitoring, detecting, signalling or eliminating infusion flow anomalies by monitoring line pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16877Adjusting flow; Devices for setting a flow rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16886Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body for measuring fluid flow rate, i.e. flowmeters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure

Definitions

  • the present invention relates to patient fluid management systems and related methods and, more particularly, to patient fluid management systems employing disposable piezoelectric driven infusion pumps.
  • infusion pumps administer fluids directly into the blood, into the body tissues, the digestive tract, the respiratory system, the mucous membranes, or the skin of a patient.
  • patient treatment often includes simultaneously administering multiple fluids to a single patient.
  • the types of fluids and the flow rates and total volumes of the fluids to be administered are determined by the patient's particular health issue, the patient's vital signs, and other real-time patient biological data obtained from various patient monitors.
  • an integrated system for precisely driving delivery of infusion fluids while simultaneously obtaining patient biological information and providing medical staff with real-time infusion status and related projections regarding a patient's fluid and pharmaceuticals status. Furthermore, in order to more efficiently utilize medical staff and to provide enhanced patient safety, a system is needed that can react or adjust operating specifications within ranges established by the medical staff, such as fluid flow rates and total infusion volumes, based on real-time patient sensor inputs.
  • a patient fluid care system provides a precise delivery of infusion fluids while simultaneously obtaining patient biological information and providing medical staff with real-time infusion status and related projections regarding a patient's fluid and pharmaceuticals status. Furthermore the patient fluid care system according to the present invention can react to or adjust a predetermined infusion protocol or plan within ranges established by the medical staff according to real-time patient information.
  • One aspect of the present invention provides real-time displays of various patient and infusion parameters. Another aspect of the present invention provides realtime patient fluid balance and pharmaceutical level information to the medical staff. In yet another aspect of the present invention, the present invention automatically adjusts a patient's predetermined infusion protocol or plan based upon real-time patient biological data received during infusion.
  • FIG. 1 is a perspective view of a patient fluid care system according to one embodiment of the present invention.
  • FIG. 2 is a perspective view of an infusion pump of a patient fluid care system according to one embodiment of the present invention.
  • FIG. 3 is a schematic of the data flow and processing of a patient fluid care system according to one embodiment of the present invention.
  • a patient fluid care system 10 provides a single interface from which a patient's nutritional or pharmacological fluids are managed and monitored.
  • a patient fluid care system 10 comprises a terminal 20 having a user interface 22.
  • the user interface 22 may, for example, comprise a touch screen display.
  • the terminal 20 serves to control one or more infusion pumps 30 which function to provide an infusion fluid from a fluid reservoir 40 to the patient 50 through patient line 60.
  • the patient line 60 may comprise a variety of different tubing and catheter systems known in the field.
  • the terminal 20 may further comprise an intravenous fluid post or stand for supporting infusion fluid reservoirs or bags 40.
  • the intravenous fluid post or stand is height adjustable.
  • the infusion pump 30 it is contemplated that a variety of types of infusion pumps, including peristaltic pumps, syringe pumps, and elastomeric pumps, can be employed as the infusion pump 30.
  • the infusion pump 30 be a microelectromechanical, or MEMS, micropump driven by a piezoelectric effect.
  • MEMS microelectromechanical
  • micropumps can be fabricated using known integrated circuit fabrication methods and technologies. For example, using integrated circuit manufacturing fabrication techniques, small channels can be formed on the surface of silicon wafers. By attaching a thin piece of material, such as glass, on the surface of the processed silicon wafer, flow paths and fluid chambers can be formed from the channels and chambers.
  • a voltage is applied to the piezoelectric body, a reverse piezoelectric effect, or vibration, is generated by the piezoelectric body and transmitted through the glass to the fluid in the chamber.
  • a resonance is produced in the fluid in the chamber of the silicon wafer.
  • the infusion pump 30 comprises a disposable body 30a and a non-disposable or reusable base 30b.
  • the disposable body 30a houses components of the infusion pump 30 that contact the infusion fluid, e.g. the piezoelectric micropump, a flow meter, not shown, and fluid inlet and outlet ports, also not shown.
  • the base 30b of the infusion pump 30 houses the control circuitry for providing power to the pump 30 and the sensing circuitry for providing flow meter data back to the terminal 20.
  • the disposable body 30a and the reusable base 30b of the infusion pump 30 are configured to mate with one another thereby creating a single pump unit 30 and establishing electrical communication between the body 30a and the base 30b.
  • the base 30b may be separate from or incorporated into the terminal 20.
  • the base 30b comprises one or more electrical connectors, not shown, for establishing electrical communication with the terminal 20.
  • the base 30b comprises a physical mount, not shown, that is complementary to a second mount that is either integrated into the terminal 20 or operable to be attached to a support structure, such as an intravenous fluid post or stand.
  • the base 30b of the infusion pump 30 further comprises one or more user interfaces 32a and 32b.
  • the interface 32a may comprise a visual indicator, such as a light, positioned on the base 30b so as to face the user and thereby provide warnings or alerts to the user.
  • the interface 32b may comprise a display that, for example, displays the name, abbreviation, or other indicator of the fluid being pumped through the same pump 30.
  • the patient fluid care system 10 further comprises a flow meter 34, shown in Fig. 3, that functions to measure actual infusion fluid flow throw the patient line 60 downstream of the infusion pump 30.
  • the flow meter 34 may comprise a variety of known flow meters.
  • the flow meter 34 may be configured to determine fluid flow rates by employing a heater that heats the fluid being monitored and senses the flow of the heated fluid downstream of the heater.
  • Such flow meters are available from Sensirion AG of Switzerland and Siargo Incorporated of the United States of America and are described in greater detail in at least U.S. Patent No. 6,813,944 to Mayer et al. and U.S. Publication No. 2009/0164163, which are herein incorporated by reference.
  • the flow meter 34 may be configured to employ two pressure sensors positioned on each side of a constriction within the fluid flow path. Fluid flow rates are determined by the relative difference between the pressure sensors and changes thereof.
  • the flow meter 34 is preferably integrated into the infusion pump 30, for example within the base 30b.
  • the terminal 20 determines and provides control factors for operation of the infusion pumps 30 based upon inputs entered into the terminal 20 via the user interface 22 or via a data network connector 24.
  • the data network connector 24 may, for example comprise a LAN, local area network, connector in data communication with a user interface at a remote location. Such remote locations may, for example, be a nursing station and/or dispensary, or doctors' room. Data network capability also facilitates use of the patient fluid care system 10 according to the present invention for homecare market.
  • control factors provided to the infusion pump 30 by the terminal 20 are determined by a combination of user inputs; sensor inputs received by the terminal 20 from one or more patient sensor; and data obtained from one or more pharmaceutical product databases or libraries. Each of these inputs will be described in greater detail below. It will be noted that in certain medical situations, it may be desirable to administer multiple infusion fluids, e.g. nutritional and pharmaceutical fluids, simultaneously to a single patient. It is contemplated that the patient terminal 20 according to the present invention, can monitor the infusion conditions for a plurality of patient lines 60, for example up to thirty patient lines 60, and can physically support and control the operation of a plurality of infusion pumps 20, for example up to thirty infusion pumps 20.
  • Fig. 3 is a schematic diagram showing the functionality and workflow of the patient fluid care system 10 according to one embodiment of the present invention.
  • the arrows indicate the direction or flow of data.
  • Housed preferably within the patient terminal 20 is a central processing unit or CPU 26 that is associated with one or more data memory units; a power supply circuitry for providing power to the infusion pump and various patient sensors; and a sensor data circuitry to receive patient sensor data from various patient sensors.
  • the patient terminal 20 is not specifically shown in Fig. 3.
  • patient data 102 is provided to the CPU 100, for example, by manually entering the data through the user interface 22 and/or by a bar code reader associated with the patient terminal 20.
  • Patient information 102 may comprise a patient's name, a patient's identification number, a patient's contact information, a patient's emergency contact, a patient's caregiver's name; a patient's caregiver's contact; and insurance provider information.
  • Patient biological data is provided to the CPU 100, for example, by manually entering the data through the user interface 22 and/or by patient sensor inputs.
  • Patient biological data comprises, for example, a patient's weight, blood pressure, insensible perspiration, urinary output, as well as a patient's other vital signs.
  • the CPU 100 is configured to be in real-time data communication with various patient sensors and monitors such as, a circulatory pressure meter 104 and a scale 106 for determining the weight or mass of a patient's urine collected in a urine bag 26, shown in Fig. 1 . It will be understood that a wide range of other patient sensors may be associated with the patient fluid care system 10 of the present invention.
  • the patient care system 10 may be associated with patient temperature sensors, heart rate sensors, and various sensors for measuring the oxygenation of a patient's hemoglobin, such as a pulse oximeter.
  • a patient's physician may input or delineate patient biological data pertaining to a patient's fluid or water balance, as well as define patient fluid balance thresholds.
  • Patient pharmacological data 108 is provided to the CPU 100, for example, by manually entering the data through the user interface 22 and/or by a bar code reader associated with the patient terminal 20.
  • the patient pharmacological data 108 may comprise data regarding the common, brand, or scientific name of a pharmaceutical to be administered to a patient, and the desired dose of the pharmaceutical.
  • data from a pharmacological database 1 12 is also provided or accessed by the CPU 100.
  • the pharmacological database 1 12 may be permanently or temporarily stored in a memory component associated with the patient fluid care systems 10 or may be accessed at a remote location through the network connector 24 of the patient terminal 20.
  • the pharmacological database 1 12, for example, may provide pre-determined standard dosages; maximum toxic dose, or MTD, which is the dosage above which toxicity may arise; minimum effective dose, or MED, which is the dose below which there is no effect; metabolic rates, e.g. the half-life of the pharmaceutical within the body, and other pharmacokinetic information.
  • Infusion data 1 10 is provided to the CPU 100, for example, by manually entering the data through the user interface 22.
  • Infusion data 1 10 may comprise data regarding the specific infusion plan or protocol in which the pharmaceutical or pharmaceuticals provided as patient pharmacological data 108 is administered to the patient through the infusion pump 20 of the patient fluid care systems 10.
  • Specific infusion data 1 10, for example, may comprise specifying a specific infusion pump 20, a flow rate of the infusion, a total volume of infusion fluid to be infused.
  • Related to the Infusion data 1 10 are the particular control factors 1 16 that direct operation of the infusion pump 30 including, for example, the voltage provided to the pump 30, the frequency at which the voltage is applied to the pump 30, and the rates at which the voltage and frequency are increased or decreased. It will be understood that the control factors 1 16 may not be directly provided by a user through the user interface 22 as the infusion data 1 10 but rather determined by the CPU 100, or rather a software module of the CPU 100, based upon the infusion datal 10.
  • patient medical history data is provided to the CPU 100 and thereby accessible from the user interface 22 of the patient terminal 20.
  • patient medical history may, for example, be accessed from an electric medical record, or EMR, system through the network connector 24 of the patient terminal 20.
  • EMR electric medical record
  • the CPU 100 and associated memory components of the patient fluid care systems 10 of the present invention includes data input logs that provide for the retrieval and review of current and previously obtained patient and pharmaceutical data.
  • the CPU 100 may further comprise software modules operable to conduct certain comparisons and calculations as will be described in greater detail below.
  • the patient fluid care system 10 Based upon the inputs described above and the continual monitoring of such inputs, the patient fluid care system 10 according to the present invention provides the user with real-time information relating to the state of a patient. Such real-time information would typically only be available to a caregiver, such as a physician, through independent and often remote medical equipment and information resources.
  • One advantage of the present invention is the consolidation and presentation of such medical information in single patient terminal or, by means of the network data compatibility, at location remote from the patient.
  • An additional advantage of the patient fluid care systems 10 is the operability of the system 10 to analyze the above-described data inputs in order to derive additional real-time patient information.
  • the patient fluid care system 10 calculates and provides real-time patient drug levels to the patient's caregiver based upon certain of the inputs relating to the patient biological data, the patient pharmacological data 108; the pharmacological database 1 12; and the infusion data 1 10 described above.
  • the CPU 100 may comprise a pharmaceutical level software module that by monitoring patient vital signs, real-time infusion volumes, and taking into consideration the pharmacokinetics of the specific drug or drugs being administered, the patient fluid care system 10 derives real-time estimates regarding the pharmaceuticals administered their quantities present in a patient's body.
  • the CPU 100 may comprise a fluid balance software module that provides caregivers with patient water balance information by utilizing the patient's urinary output data which is determined by data received from the scale 106 that continually weighs the patient's urine bag, the infusion data regarding the volume of water and other fluids infused into the patient up to that time; and the patient's volume of insensible perspiration.
  • the water management information derived by the patient fluid care system 10 can be used by physicians in determining subsequent patient treatments. For example, in medical settings such as those for premature infants in which infusion volumes must be closely monitored due to the patient's small size, the concentration of pharmaceutical products are selected on the basis of the infant's water balance data, i.e. the amount of urine and insensible perspiration lost and the total infusion quantity input. Furthermore, a patient's fluid balance is of significant importance during central venous hyperalimentation in which high volumes of infusion fluids can potentially place hazardous loads on a patient's heart and kidneys.
  • the patient fluid care system 10 is also operable to utilize the above described data inputs and calculated patient pharmaceutical levels and fluid balance in order to automatically adjust patient infusion protocols or plans within the parameters originally set by the physician.
  • the CPU 100 may comprise a compensation software module to determine and implement these automatic adjustments. More particularly, in operation, the physician or caregiver will enter in to the patient fluid care system 10 the patient's infusion plan, e.g. the volume of the pharmaceutical to be administered and the flow rate at which the pharmaceutical will be administered. Additionally, the physician may set certain parameters and stipulations within which the infusion plan will be administered. If, for example, central venous hyperalimentation is being administered, the physician may enter an initial infusion flow rate and final infusion volume that are not to be exceeded.
  • the physician may further instruct the system 10 to monitor a patient's urinary output and if during infusion, the urinary output is below a set threshold, the infusion will automatically adjust infusion flow rates or terminate infusion.
  • a patient's blood pressure may be managed by administering catecholamines and beta blockers, which are counterbalancing pharmaceutical products.
  • blood pressure is controlled by administering multiple drugs that are often antagonistic having different mechanisms of action.
  • the patient fluid care system 10 allows the physician to set up infusion plans that will automatically administer such antagonistic pharmaceuticals based upon inputs from a patient sensor such as blood pressure.
  • the automatic control can be performed, including stipulating antagonistic pharmaceuticals within a range of infusion and biological sensor inputs determined by the medical staff.
  • the patient fluid care system 10 can execute MTD and MED warnings or alarms to notify medical staff.
  • the patient fluid care systems 10 further comprises a simulation function.
  • the simulation function estimates patient fluid balances at a projected time during infusion, for example, at the time infusion of a pharmaceutical is contemplated to start.
  • the patient fluid care system 10 of the present invention is particularly advantageous in that while at a patient's bedside, a physician may access and view pages displaying data compilations through the patient terminal 20 and the software functionality of the patient fluid care systems 10.
  • Such pages may, for example, display the infusion status of each pharmaceutical being infused, including the dose remaining in the patient body; display infusion status of each pharmaceutical by grouping; and display the patient's water or fluid balance.
  • the patient fluid care system 10 of the present invention is particularly advantageous in that the micropump 30 of the infusion pump 10 does not exchange data with the patient terminal 20, i.e. the electrical communication between the micropump 30 and the patient terminal 20 is one-way, from the patient terminal 20 to the micropump 30.
  • the micropump 30 is a slave to the patient terminal 20.
  • This configuration is advantageous because it provides for a simplified and more economical infusion pump 10.
  • the circuitry within the micropump 30 is simplified and thereby more economical to manufacture.
  • a hospital or clinic may more economically obtain the disposable portions of the patient fluid care system 10 and only have to acquire and maintain a limited number of the more complex and more costly patient terminals 20.
  • the patient fluid care system 10 employing data network capabilities and a piezoelectric driven infusion pumps are especially well suited for homecare deployment because they may be configured to monitor a patient's central venous pressure without the need for conventional, costly central venous pressure monitoring equipment.
  • This functionality is described in greater detail in the Assignee's copending U.S. Patent Application No. (TBD) entitled CIRCULATORY PRESSURE MONITORING USING INFUSION PUMP SYSTEMS, the contents of which are herein incorporated in their entirety.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
EP10838333A 2009-12-18 2010-12-17 Patient fluid management system Withdrawn EP2512545A2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US28788109P 2009-12-18 2009-12-18
US28799109P 2009-12-18 2009-12-18
US28790309P 2009-12-18 2009-12-18
US28791209P 2009-12-18 2009-12-18
PCT/US2010/061162 WO2011075708A2 (en) 2009-12-18 2010-12-17 Patient fluid management system

Publications (1)

Publication Number Publication Date
EP2512545A2 true EP2512545A2 (en) 2012-10-24

Family

ID=46634701

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10838333A Withdrawn EP2512545A2 (en) 2009-12-18 2010-12-17 Patient fluid management system

Country Status (3)

Country Link
EP (1) EP2512545A2 (ja)
JP (1) JP2013514838A (ja)
CA (1) CA2783606A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2580307A (en) * 2018-12-12 2020-07-22 Osama Al Baalbaky Alaa Smart self-monitored syringe infusion pump

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7299230B2 (ja) * 2018-03-01 2023-06-27 マシモ・コーポレイション 自律型薬物送達システム
DE102018211392A1 (de) * 2018-07-10 2020-01-16 B. Braun Melsungen Ag Infusionsanordnung zur Verabreichung eines medizinischen Fluids
WO2024021023A1 (zh) * 2022-07-29 2024-02-01 深圳麦科田生物医疗技术股份有限公司 药物输注调节方法、装置及药物输注设备

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2011075708A3 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2580307A (en) * 2018-12-12 2020-07-22 Osama Al Baalbaky Alaa Smart self-monitored syringe infusion pump

Also Published As

Publication number Publication date
CA2783606A1 (en) 2011-06-23
JP2013514838A (ja) 2013-05-02

Similar Documents

Publication Publication Date Title
US7029455B2 (en) Devices, systems and methods for patient infusion
US8016798B2 (en) Fluid delivery system and sensing unit therefor
GB2442835A (en) System for controlling and monitoring therapy modules of a medical workplace
JP2004524869A (ja) 患者の輸液システム用のデータ収集アセンブリ
AU2001288575A1 (en) Devices, systems and methods for patient infusion
WO2005018718A1 (en) Infusion spike with micro-electromechanical (mems) element
WO2013138537A1 (en) Medical flow rate monitor and method of use
US20230405198A1 (en) Personalized renal failure chronic care systems and methods
Rosdi et al. A smart infusion pump system for remote management and monitoring of intravenous (IV) drips
EP2512545A2 (en) Patient fluid management system
US20110152829A1 (en) Patient Fluid Management System
EP2869763A1 (en) Glucose consumption monitor
US20180369478A1 (en) Medical infusion pumps and systems
GB2580307A (en) Smart self-monitored syringe infusion pump
JP2023022025A5 (ja)
WO2017089615A1 (en) Infusion system
WO2020016110A1 (en) System and device to monitor multiple infusions
Daimiwal et al. Wireless transfusion supervision and analysis using embedded system
WO2011075709A1 (en) Circulatory pressure monitoring using infusion pump systems
EP2512582A1 (en) Circulatory pressure monitoring using infusion pump systems
Abdullah et al. Low-cost BLE based intravenous monitoring and control infusion system
Weinstein Nursing considerations: Flow control

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120611

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160701